Tiletamine-Zolazepam

10 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

3000.0%

Death Rate

Active Ingredients

Tiletamine-Zolazepam

Administration Routes

IntramuscularIntravenousUnknown

Species Affected

Dog 5

Cat 3

Pig 2

Most Affected Breeds

Cat (unknown) 3

Corgi (unspecified) 3

Landrace (other) 2

Crossbred Canine/dog 1

Terrier - Airedale 1

Most Reported Reactions

Myocarditis 4

Heart failure 4

Cardiac disorder NOS 4

Abnormal ultrasound finding 4

Pulmonary oedema 4

Abnormal radiograph finding 4

Dyspnoea 4

Death 3

Decreased appetite 3

Anorexia 3

Lethargy (see also Central nervous system depression in Neurological) 3

Elevated temperature 3

Outcome Breakdown

Recovered/Normal

4 (36.4%)

Outcome Unknown

3 (27.3%)

Died

2 (18.2%)

Ongoing

1 (9.1%)

Euthanized

1 (9.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.